The Crisis of Care: Caily Confronts Caregiver Burnout with Launch of Comprehensive Digital Platform in Summer 2025
Denver, CO, June 02, 2025 (GLOBE NEWSWIRE) -- As caregiver burnout reaches…
NYSE Content Advisory: Pre-Market update + U.S. – China trade tensions escalate
NEW YORK, June 2, 2025 /PRNewswire/ -- The New York Stock Exchange…
Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with TE
Real-world claims studies evaluating UZEDY® (risperidone) also show improved adherence and persistence…
How to make over $10,000 a day: XRP enthusiasts realize their dreams on the SAVVY MINING platform.
New York City, USA, May 30, 2025 (GLOBE NEWSWIRE) -- XRP is…
NYSE Content Advisory: Pre-Market update + April inflation data released
NEW YORK, May 30, 2025 /PRNewswire/ -- The New York Stock Exchange…
NYSE Content Advisory: Pre-Market update + Nvidia, Salesforce beat on earnings
NEW YORK, May 29, 2025 /PRNewswire/ -- The New York Stock Exchange…
NYSE Content Advisory: Pre-Market update + CEO survey reveals growth as top priority
NEW YORK, May 28, 2025 /PRNewswire/ -- The New York Stock Exchange…
Beko Announces Updates to HomeWhiz Platform to Advance Smart Appliance Efficiency and Sustainability
HomeWhiz can be operated from anywhere aims to optimize appliance performance, reduce…
NYSE Content Advisory: Pre-Market update + Hinge Health, MNTN rise in their first full day of trade
NEW YORK, May 27, 2025 /PRNewswire/ -- The New York Stock Exchange…
Mineralys Therapeutics Announces Late-Breaking Presentation of Data from the Launch-HTN Pivotal Trial of Lorundrostat in Uncontrolled or Resistant Hypertension at 34th European Meeting on Hypertension and Cardiovascular Protection (ESH 2025)
– Largest hypertension trial of an aldosterone synthase inhibitor to date demonstrated…